Localizing synaptic mRNAs at the neuromuscular junction: It takes more than transcription

BioEssays

Volumn 25, Issue 1, 2003, Pages 25-31

  Chakkalakal, Joe V ^b   Jasmin, Bernard J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037232946     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10205     Document Type: Review

References (90)

1. Fischbach GD, Rosen KM. ARIA:a neuromuscular junction neuregulin. Annu Rev Neurosci 1997;20:429-458.
2. Goldman D, Sapru MK. Molecular mechanisms mediating synapse-specific gene expression during development of the neuromuscular junction. Can J Appl Physiol 1998;23:390-395.
3. Burden SJ. The formation of neuromuscular synapses. Genes Dev 1998;12:133-148.
4. Sanes JR, Lichtman JW. Development of the vertebrate neuromuscular junction. Annu Rev Neurosci 1999;22:389-442.
5. Schaeffer L, de Kerchove d'Exaerde A, Changeux JP. Targeting Transcription to the Neuromuscular Synapse. Neuron 2001;31:15-22.
6. Merlie JP, Sanes JR. Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibres. Nature 1985;317:66-68.
7. Fontaine B, Sassoon D, Buckingham M, Changeux JP. Detection of the nicotinic acetylcholine receptor alpha-subunit mRNA by in situ hybridization at neuromuscular junctions of 15-day-old chick striated muscles. EMBO J 1988;7:603-609.
8. Goldman D, Staple J. Spatial and temporal expression of acetylcholine receptor RNAs in innervated and denervated rat soleus muscle. Neuron 1989;3:219-228.
9. Jasmin BJ, Lee RK, Rotundo RL. Compartmentalization of acetylcholinesterase mRNA and enzyme at the vertebrate neuromuscular junction. Neuron 1993;11:467-477.
10. Michel RN, Vu CQ, Tetzlaff W, Jasmin BJ. Neural regulation of acetylcholinesterase mRNAs at mammalian neuromuscular synapses. J Cell Biol 1994;127:1061-1069.
11. Moscoso LM, Merlie JP, Sanes JR. N-CAM, 43K-rapsyn, and S-laminin mRNAs are concentrated at synaptic sites in muscle fibers. Mol Cell Neurosci 1995;6:80-89.
12. Valenzuela DM, et al. Receptor tyrosine kinase specific for the skeletal muscle lineage:expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 1995;15:573-584.
13. Imaizumi-Scherrer T, Faust DM, Benichou JC, Hellio R, Weiss MC. Accumulation in fetal muscle and localization to the neuromuscular junction of cAMP-dependent protein kinase A regulatory and catalytic subunits RI alpha and C alpha. J Cell Biol 1996;134:1241-1254.
14. Gramolini AO, Dennis CL, Tinsley JM, Robertson GS, Cartaud J, Davies KE, Jasmin BJ. Local transcriptional control of utrophin expression at the neuromuscular synapse. J Biol Chem 1997;272:8117-8120.
15. Vater R, Young C, Anderson LVB, Lindsay S, Blake DJ, Davies KE, Zuellig R, Slater CR. Utrophin mRNA Expression in Muscle Is Not Restricted to the Neuromuscular Junction. Mol Cell Neurosci 1998;10:229-242.
16. Moore C, Leu M, Muller U, Brenner HR. Induction of multiple signaling loops by MuSK during neuromuscular synapse formation. Proc Natl Acad Sci USA 2001;98:14655-14660.
17. Duclert A, Changeux JP. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol Rev 1995;75:339-368.
18. Jasmin BJ, Gramolini AO, Adatia FA, Angus L, Boudreau-Lariviere C, Chan RY, Krupa AM, Lunde JA, Mankal FA, Wu J. Nerve-derived trophic factors and DNA elements controlling expression of genes encoding synaptic proteins in skeletal muscle fibers. Can J Appl Physiol 1998;23:366-376.
19. Koike S, Schaeffer L, Changeux JP. Identification of a DNA element determining synaptic expression of the mouse acetylcholine receptor delta-subunit gene. Proc Natl Acad Sci USA 1995;92:10624-10628.
20. Duclert A, Savatier N, Schaeffer L, Changeux JP. Identification of an element crucial for the sub-synaptic expression of the acetylcholine receptor epsilon-subunit gene. J Biol Chem 1996;271:17433-17438.
21. Fromm L, Burden SJ. Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABPbeta. Genes Dev 1998;12:3074-3083.
22. Sapru MK, Florance SK, Kirk C, Goldman D. Identification of a neuregulin and protein-tyrosine phosphatase response element in the nicotinic acetylcholine receptor epsilon subunit gene:regulatory role of an Rts transcription factor. Proc Natl Acad Sci USA 1998;95:1289-1294.
23. Schaeffer L, Duclert N, Huchet-Dymanus M, Changeux JP. Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor. EMBO J 1998;17:3078-3090.
24. Chan RY, Boudreau-Lariviere C, Angus LM, Mankal FA, Jasmin BJ. An intronic enhancer containing an N-box motif is required for synapse- and tissue-specific expression of the acetylcholinesterase gene in skeletal muscle fibers. Proc Natl Acad Sci USA 1999;96:4627-4632.
25. Gramolini AO, Angus LM, Schaeffer L, Burton EA, Tinsley JM, Davies KE, Changeux JP, Jasmin BJ. Induction of utrophin gene expression by heregulin in skeletal muscle cells:role of the N-box motif and GA binding protein. Proc Natl Acad Sci USA 1999;96:3223-3237.
26. Khurana TS, Rosmarin AG, Shang J, Krag TO, Das S, Gammeltoft S. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta. Mol Biol Cell 1999;10:2075-2086.
27. Briguet A, Ruegg MA. The Ets transcription factor GABP is required for postsynaptic differentiation in vivo. J Neurosci 2000;20:5989-5996.
28. Kerchove d'Exaerde A, Cartaud J, Jasmin BJ, Changeux JP, Schaeffer L. Motor endplate malformation and alterations in gene expression consecutive to muscle-specific expression of a dominant negative version of an Ets transcription factor. EMBO Rep (acceptable with revisions, 2002).
29. Nichols P, Croxen R, Vincent A, Rutter R, Hutchinson M, Newson-Davis J, Beeson D. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. Ann Neurol 1999;45:439-443.
30. Ohno K, Anlar B, Engel AG. Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene. Neuromuscul Disord 1999;9:131-135.
31. Sigrist SJ, Thiel PR, Reiff DF, Lachance PE, Lasko P, Schuster CM. Postsynaptic translation affects the efficacy and morphology of neuromuscular junctions. Nature 2000;405:1062-1065.
32. Zhang YQ, Bailey AM, Matthies HJ, Renden RB, Smith MA, Speese SD, Rubin GM, Broadie K. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 2001;107:591-603.
33. Jasmin BJ, Cartaud J, Bornens M, Changeux JP. Golgi apparatus in chick skeletal muscle:changes in its distribution during end plate development and after denervation. Proc Natl Acad Sci USA 1989;86:7218-7222.
34. Jasmin BJ, Antony C, Changeux JP, Cartaud J. Nerve-dependent plasticity of the Golgi complex in skeletal muscle fibres:compartmentalization within the subneural sarcoplasm. Eur J Neurosci 1995;7:470-479.
35. Jasmin BJ, Changeux JP, Cartaud J. Compartmentalization of cold-stable and acetylated microtubules in the subsynaptic domain of chick skeletal muscle fibre. Nature 1990;344:673-675.
36. Marchand S, Cartaud J. Targeted trafficking of neurotransmitter receptors to synaptic sites. Mol Neurobiol in press, 2002.
37. Thompson J, Jasmin BJ. Unpublished observations.
38. Newey SE, Gramolini AO, Wu J, Holzfeind P, Jasmin BJ, Davies KE, Blake DJ. A novel mechanism for modulating synaptic gene expression:differential localization of alpha-dystrobrevin transcripts in skeletal muscle. Mol Cell Neurosci 2001;17:127-140.
39. Straub V, Campbell KP. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol 1997;10:168-175.
40. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002;82:291-329.
41. Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genet 1996;12:171-175.
42. Day DA, Tuite MF. Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 1998;157:361-371.
43. Grzybowska EA, Wilczynska A, Siedlecki JA. Regulatory functions of 3'UTRs. Biochem Biophys Res Commun 2001;288:291-295.
44. Malter JS. Regulation of mRNA stability in the nervous system and beyond. J Neurosci Res 2001;66:311-316.
45. Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002;3:195-205.
46. Grunert S, St. Johnston D. RNA localization and the development of asymmetry during Drosophila oogenesis. Curr Opin Genet Dev 1996;6:395-402.
47. Hesketh JE. mRNA targeting:signals in the 3′-untranslated sequences for sorting of some mRNAs. Biochem Soc Trans 1996;24:521-527.
48. Gao FB. Messenger RNAs in dendrites:localization, stability, and implications for neuronal function. BioEssays 1998;20;70-78.
49. Bassell GJ, Singer RH. Neuronal RNA localization and the cytoskeleton. Results Probl Cell Differ 2001;34:41-56.
50. Steward O, Schuman EM. Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 2001;24:299-325.
51. Winder SJ. The membrane-cytoskeleton interface:the role of dystrophin and utrophin. J Muscle Res Cell Motil 1997;18:617-629.
52. Rafael JA, Brown SC. Dystrophin and utrophin:genetic analyses of their role in skeletal muscle. Microsc Res Tech 2000;48:155-166.
53. Krag TO, Gyrd-Hansen M, Khurana TS. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. Acta Physiol Scand 2001;171:349-358.
54. Jasmin BJ, Angus LM, Belanger G, Chakkalakal JV, Gramolini AO, Lunde JA, Stocksley MA, Thompson J. Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers:insights into a therapeutic strategy for Duchenne muscular dystrophy. J Physiol Paris 2002;96:31-42.
55. Gramolini AO, Belanger G, Jasmin BJ. Distinct regions in the 3′ untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells. J Cell Biol 2001;154:1173-1183.
56. Hall ZW, Lubit BW, Schwartz JH. Cytoplasmic actin in postsynaptic structures at the neuromuscular junction. J Cell Biol 1981;90:789-792.
57. Bélanger G, Stocksley MA, Schaeffer L, DesGroseillers L, Jasmin BJ. Expression and localization of Staufen at the mammalian neuromuscular junction. Submitted, 2002.
58. Fuentes ME, Taylor P. Control of acetylcholinesterase gene expression during myogenesis. Neuron 1993;10:679-687.
59. Grubic Z, Komel R, Walker WF, Miranda AF. Myoblast fusion and innervation with rat motor nerve alter distribution of acetylcholinesterase and its mRNA in cultures of human muscle. Neuron 1995;14:317-327.
60. Angus LM, Chan RY, Jasmin BJ. Role of intronic E- and N-box motifs in the transcriptional induction of the acetylcholinesterase gene during myogenic differentiation. J Biol Chem 2001;276:17603-17609.
61. Luo ZD, Wang Y, Werlen G, Camp S, Chien KR, Taylor P. Calcineurin enhances acetylcholinesterase mRNA stability during C2-C12 muscle cell differentiation. Mol Pharmacol 1999;56:886-894.
62. Luo ZD, Pincon-Raymond M, Taylor P. Acetylcholinesterase and nicotinic acetylcholine receptor expression diverge in muscular dysgenic mice lacking the L-type calcium channel. J Neurochem 1996;67:111-118.
63. Luo Z, Fuentes ME, Taylor P. Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes. J Biol Chem 1994;269:27216-27223.
64. Cresnar B, Crne-Finderle N, Breskvar XX, Sketelj J. Neural regulation of muscle acetylcholinesterase is exerted on the level of its mRNA. J Neurosci Res 1994;38:294-299.
65. Boudreau-Lariviere C, Chan RY, Wu J, Jasmin BJ. Molecular mechanisms underlying the activity-linked alterations in acetylcholinesterase mRNAs in developing versus adult rat skeletal muscles. J Neurochem 2000;74:2250-2258.
66. Tsay HJ, Schmidt J. Skeletal muscle denervation activates acetylcholine receptor genes. J Cell Biol 1989;108:1523-1526.
67. Fontaine B, Klarsfeld A, Changeux JP. Calcitonin gene-related peptide and muscle activity regulate acetylcholine receptor alpha-subunit mRNA levels by distinct intracellular pathways. J Cell Biol 1987;105:1337-1342.
68. Pette D, Staron RS. Mammalian skeletal muscle fiber type transitions. Int Rev Cytol 1997;170:143-223.
69. Schiaffino S, Regglani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996;76:371-423.
70. Gramolini AO, Belanger G, Thompson JM, Chakkalakal JV, Jasmin BJ. Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. Am J Physiol Cell Physiol 2001;281:C1300-C1309.
71. Mahadevan MS, et al. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum Mol Genet 1993;2:299-304.
72. Brook JD, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
73. van der Ven PF, et al. Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum Mol Genet 1993;2:1889-9184.
74. Whiting EJ, Waring JD, Tamai K, Somerville MJ, Hincke M, Staines WA, Ikeda JE, Korneluk RG. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. Hum Mol Genet 1995;4:1063-1072.
75. Tapscott SJ, Thornton CA. Biomedicine. Reconstructing myotonic dystrophy. Science 2000;293:816-817.
76. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996;24;4407-4414.
77. Timchenko LT, Timchenko NA, Caskey CT, Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeat-simplications for myotonic dystrophy. Hum Mol Genet 1996;5:115-121.
78. Tian B, White RJ, Xia T, Welle S, Turner DH, Mathews MB, Thornton CA. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 2000;6:79-87.
79. Tiscornia G, Mahadevan MS. Myotonic dystrophy:the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol Cell 2000;5:959-967.
80. Miller JW, Urbinati CR, Teng-Umnuax P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000;19:4439-4448.
81. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, Andrade FH. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002;11:263-272.
82. Velleca MA, Wallace MC, Merlie JP. A novel synapse-associated noncoding RNA. Mol Cell Biol 1994;14:7095-7104.
83. Storz G. An expanding universe of non-coding RNAs. Science 2002;296:1260-1263.
84. Rajagopalan LE, Malter JS. Regulation of eukaryotic messenger RNA turnover. Prog Nucleic Acid Res Mol Biol 1997;56:257-286.
85. Mohr E. Subcellular RNA compartmentalization. Prog Neurobiol 1999;57:507-525.
86. Kiebler MA, DesGroseillers L. Molecular insights into mRNA transport and local tramslocation in the mammalian nervous system. Neuron 2000;25:19-28.
87. Wells DG, Richter JD, Fallon JR. Molecular mechanisms for activity-regulated protein synthesis in the synaptodendritic compartment. Curr Opin Neurobiol 2000;10:132-137.
88. Palacios IM, Johnston DS. Getting the message across:the intracellular localization of mRNAs in higher eukaryotes. Annu Rev Cell Dev Biol 2001;17:569-614.
89. Steward O, Worley PF. A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc Natl Acad Sci USA 2001;98:7062-7068.
90. Perrone-Bizzozero N, Bolognani F. Role of HuD and other RNA-binding proteins in neural development and plasticity. J Neurosci Res 2002;68:121-126.